Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-length microneedle patch delivering botulinum toxin type A for enlarged cheek pores in Thai participants
TCTR20251209008Phase 2Recruiting
- Sponsor
- Merz
- Start
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A, sponsored by Merz. Started Nov 2025; status: recruiting.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on TCTR20251209008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251209008.